“Experiencing the dramatic change in quality of life of patients being rendered insulin free is extremely rewarding.”
David Baidal, M.D.
David Baidal, M.D., is Assistant Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of Miami Miller School of Medicine. He is also a member of the DRI’s Clinical Islet Transplant Program. Dr. Baidal received his medical degree from Universidad Católica Santiago de Guayaquil in Ecuador. He completed his internal medicine residency at Jackson Memorial Hospital, University of Miami and then went on to complete a clinical and research fellowship in Endocrinology, Diabetes & Metabolism at the Beth Israel Deaconess Medical Center / Joslin Diabetes Center in Boston.
Dr. Baidal is a former member of the Clinical Islet Transplant Program at the Diabetes Research Institute, having trained under Dr. Rodolfo Alejandro and Dr. Camillo Ricordi, where his research primarily focused on the identification of metabolic markers predictive of islet allograft dysfunction.
Following completion of his clinical fellowship, he rejoined the Clinical Cell Transplant Program at the Diabetes Research Institute, where he focuses on the management of islet transplant recipients and the development of new clinical trials for islet transplantation and testing novel therapies for the treatment of new onset type 1 diabetes. Dr. Baidal is also involved in the care of subjects with endocrine problems, in particular type 1 diabetes.
Islet Transplant Recipients with Long-Term Insulin Indepedence Show Near-Normal Glucose Control
Bioengineering of an Intraabdominal Endocrine Pancreas
Early Metabolic Markers of Islet Allograft Dysfunction
A Decade of Freedom from Insulin Injections
Phase I/II Clinical Trial Testing the Omentum